EcoDrugPlus

Tubulin Beta Class I

Ensembl ID : ENSFCAG00000027444
Gene Symbol: TUBB
5 Cross references
267 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSFCAG00000009623
Gene Symbol: TP53
5 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSFCAG00000024128
Gene Symbol: TYR
5 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSFCAG00000006939
Gene Symbol: TH
5 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSFCAG00000009436
Gene Symbol: TYK2
3 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSFCAG00000015111
Gene Symbol: TIE1
5 Cross references
205 Possible Orthologues:

Utrophin

Ensembl ID : ENSFCAG00000012433
Gene Symbol: UTRN
5 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSFCAG00000026462
Gene Symbol: VEGFA
5 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSFCAG00000024594
Gene Symbol: VDR
5 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSFCAG00000029684
Gene Symbol: VKORC1
5 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSFCAG00000004557
Gene Symbol: XDH
4 Cross references
205 Possible Orthologues:

Ensembl ID : ENSFCAG00000013138
Gene Symbol: -
1 Cross references
324 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).